VIR
NASDAQ · Biotechnology
Vir Biotechnology Inc
$8.90
+0.24 (+2.77%)
Open$8.91
Previous Close$8.66
Day High$9.06
Day Low$8.55
52W High$11.66
52W Low$4.16
Volume—
Avg Volume1.60M
Market Cap1.47B
P/E Ratio—
EPS$-3.16
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+90.8% upside
Current
$8.90
$8.90
Target
$16.98
$16.98
$13.41
$16.98 avg
$22.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 81.66M | 234.12M | 113.39M |
| Net Income | -521,735,633 | -1,346,221,530 | -30,823,495 |
| Profit Margin | -638.9% | -606.9% | -27.2% |
| EBITDA | -570,511,702 | -1,553,859,280 | -42,153,177 |
| Free Cash Flow | — | — | -22,930,380 |
| Rev Growth | -65.1% | -65.1% | +24.3% |
| Debt/Equity | — | — | 0.94 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |